Abstract
The spread of the disease caused by monkeypox virus (MPox) since 2022 has shown the urgency of developing countermeasures. The development of modern methods of clinical laboratory diagnostics of MPox contributes to this. Enzyme-linked immunosorbent assay (ELISA) is an accessible and sensitive platform for developing diagnostic tools. Detection of MPox antigens using ELISA kits based on monoclonal antibodies (MAbs) is promising due to the quick time of analysis and minimal requirements for sample preparation. We have developed and deposited two strains of Escherichia coli that produce recombinant proteins. Mice were immunized with the AgPOX protein, which contains unique antigenic sequences of MPox. The Trx + A29 protein for selecting MAb producers includes the original amino acid sequence A29L. The absence of antibody crossover to Trx protein and native preparations of variola virus and vaccinia virus tested by ELISA. As a result of hybridization of splenocytes from immunized mice, MAb producers were obtained. Fifteen MAb-producing hybridomas were selected based on ELISA results with three specific MPox antigens and three nonspecific ones. Three hybridomas were selected for deposit according to the productivity criteria. The possibility of detection by means of its MAbs of the native MPox antigen at various concentrations was tested and method sensitivity was determined. The MAbs a-A29L_MPoxV of three hybridomas detected the native antigen MPox at a concentration of 102 PFU/mL. It is likely that the method is even more sensitive when selecting analysis conditions. Based on labeled MAbs a-A29L_MPoxV, it is possible to develop a sensitive and specific indirect two-step ELISA kit for immunodiagnostics of MPox.
REFERENCES
Zhang, Y., Zhou, Y., Pei, R., Chen, X., and Wang, Y., Potential threat of human pathogenic orthopoxviruses to public health and control strategies, J. Biosaf. Biosecur., 2023, vol. 5, no. 1, pp. 1–7. https://doi.org/10.1016/j.jobb.2022.12.004
Postanovlenie Glavnogo gosudarstvennogo sanitarnogo vracha RF ot 28.01.21 No. 4 “Ob utverzhdenii sanitarnykh pravil i norm SanPiN 3.3686-21 “Sanitarno-epidemiologicheskie trebovaniya po profilaktike infektsionnykh boleznei” (Decree of the Chief State Sanitary Doctor of the Russian Federation Dated January 28, 2021 No. 4 “On Approval of Sanitary Rules and Norms SanPiN 3.3686-21 “Sanitary and Epidemiological Requirements for Preventing Infectious Diseases”), Moscow, 2021. https://base.garant.ru/400342149/?ysclid=lmpx9sn6gb601578034. Accessed September 19, 2023.
Sklenovská, N. and Van Ranst, M., Emergence of monkeypox as the most important orthopoxvirus infection in humans, Front. Public Health, 2018, vol. 6, p. 241. https://doi.org/10.3389/fpubh.2018.00241
Arita, I. and Henderson, D.A., Smallpox and monkeypox in nonhuman primates, Bull. W. H. O., 1968, vol. 39, pp. 277–283.
Arita, I., Jezek, Z., Khodakevich, L., and Ruti, K., Human monkeypox: A newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa, Am. J. Trop. Med. Hyg., 1985, vol. 34, pp. 781–789. https://doi.org/10.4269/ajtmh.1985.34.781
Di Giulio, D.B. and Eckburg, P.B., Human monkeypox: An emerging zoonosis, Lancet Infect. Dis., 2004, vol. 4, pp. 15–25. https://doi.org/10.1016/S1473-3099(03)00856-9
Huhn, G.D., Bauer, A.M., Yorita, K., Graham, M.B., Sejvar, J., Likos, A., et al., Clinical characteristics of human monkeypox, and risk factors for severe disease, Clin. Infect. Dis., 2005, vol. 41, no. 12, pp. 1742–1751. https://doi.org/10.1086/498115
Marennikova, S.S. and Shchelkunov, S.N., Patogennye dlya cheloveka ortopoksvirusy (Orthopoxviruses Pathogenic to Humans), Moscow: Tovarishchestvo nauchnykh izdanii KMK, 1998, p. 38.
Likos, A.M., Sammons, S.A., Olson, V.A., Frace, A.M., Li, Y., Olsen-Rasmussen, M., Davidson, W., Galloway, R., Khristova, M.L., Reynolds, M.G., Zhao, H., Carroll, D.S., Curns, A., Formenty, P., Esposito, J.J., Regnery, R.L., and Damon, I.K., A tale of two clades: Monkeypox viruses, J. Gen. Virol., 2005, vol. 86, part 10, pp. 2661–2672. https://doi.org/10.1099/vir.0.81215-0
Chen, N., Li, G., Liszewski, M.K., Atkinson, J.P., Jahrling, P.B., Feng, Z., et al., Virulence differences between monkeypox virus isolates from West Africa and the Congo Basin, Virology, 2005, vol. 340, no. 1, pp. 46–63. https://doi.org/10.1016/j.virol.2005.05.030
Saijo, M., Ami, Y., Suzaki, Y., Nagata, N., Iwata, N., Hasegawa, H., et al., Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates, J. Gen. Virol., 2009, vol. 90, part 9, pp. 2266–2271. https://doi.org/10.1099/vir.0.010207-0
WHO, 2022-23 Mpox (Monkeypox) Outbreak: Global Trends. https://www.who.int/publications/m/item/ multi-country-outbreak-ofmpox–external-situation-report-28—19-september-2023. Accessed October 2, 2023.
Dyall, J., Johnson, R.F., Chen, D.Y., Huzella, L., Ragland, D.R., Mollura, D.J., et al., Evaluation of monkeypox disease progression by molecular imaging, J. Infect. Dis., 2011, vol. 204, no. 12, pp. 1902–1911. https://doi.org/10.1093/infdis/jir663
Dubois, M.E. and Slifka, M.K., Retrospective analysis of monkeypox infection, Emerging Infect. Dis., 2008, vol. 14, no. 4, pp. 592–599. https://doi.org/10.3201/eid1404.071044
Ushkalenko, N.D., Ersh, A.V., Filatov, P.V., and Poltavchenko, A.G., The rapid ELISA method for detection of orthopoxviruses, Probl. Virol., 2023, vol. 68, no. 3, pp. 242–251. https://doi.org/10.36233/0507-4088-178
Hughes, L.J., Goldstein, J., Pohl, J., Hooper, J.W., Lee Pitts, R., Townsend, M.B., et al., A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27, Virology, 2014, vols. 464–465, pp. 264–273. https://doi.org/10.1016/j.virol.2014.06.039
Maniatis, T., Fritsch, E.E., and Sambrook, J., Molecular Cloning, Cold Spring Harbor Laboratory, 1982.
Reed, L.J. and Muench, H., A simple method of estimating fifty per cent endpoints, Am. J. Epidemiol., 1938, vol. 27, pp. 493–497. https://doi.org/10.1093/oxfordjournals.aje.a118408
Chang, T.H., Chang, S.J., Hsieh, F.L., Ko, T.P., Lin, C.T., Ho, M.R., et al., Crystal structure of vaccinia viral A27 protein reveals a novel structure critical for its function and complex formation with A26 protein, PLoS Pathog., 2013, vol. 9, no. 8, p. e1003563. https://doi.org/10.1371/journal.ppat.1003563
ACKNOWLEDGMENTS
The authors are grateful to Andrei Leonidovich Matveev, Senior Researcher of the Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, for his invaluable contribution to the creation of hybridomas and editing the article.
Funding
The study was supported by the state order GZ-34/21 to the State Scientific Center of Virology and Biotechnology “VECTOR,” project no. 121033100069-4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
CONFLICT OF INTEREST
The authors of this work declare that they have no conflicts of interest.
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
Animal-related experiments were conducted in accordance with the NIH Guidelines for the care and use of laboratory animals (http://oacu.od.nih.gov/regs/index.htm). Animal protocols were approved by the Bioethics Committee of the State Scientific Center of Virology and Biotechnology “VECTOR.”
Additional information
Translated by A. Kazantseva
Publisher’s Note.
Allerton Press remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Pyankov, S.A., Shulgina, I.S., Rybel, A.V. et al. Application of A29L Protein Specific Monoclonal Antibodies A-A29L_MPoxV for Monkeypox Diagnosis. Mol. Genet. Microbiol. Virol. 38, 242–248 (2023). https://doi.org/10.3103/S0891416823040067
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0891416823040067